| Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA LG Hill, LJ Loera, KE Evoy, ML Renfro, SB Torrez, CM Zagorski, JC Perez, ... Addiction 116 (6), 1505-1511, 2021 | 50 | 2021 |
| Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 US states LG Hill, LJ Loera, SB Torrez, T Puzantian, KE Evoy, DJ Ventricelli, ... Drug and alcohol dependence 237, 109518, 2022 | 25 | 2022 |
| Reducing the harms of xylazine: clinical approaches, research deficits, and public health context CM Zagorski, RA Hosey, C Moraff, A Ferguson, M Figgatt, S Aronowitz, ... Harm reduction journal 20 (1), 141, 2023 | 16 | 2023 |
| Increasingly powerful opioid antagonists are not necessary LG Hill, CM Zagorski, LJ Loera The International Journal on Drug Policy 99, 103457, 2022 | 15 | 2022 |
| Isotonitazene as a contaminant of concern in the illegal opioid supply: a practical synthesis and cost perspective CM Zagorski, JM Myslinski, LG Hill The International journal on drug policy 86, 102939, 2020 | 10 | 2020 |
| A qualitative exploration of unintentional versus intentional exposure to fentanyl among people who use drugs in Austin, TX JD Cance, A Bingaman, H Kane, S Hairgrove, SB Torrez, A Buck, ... Journal of the American Pharmacists Association 63 (1), 317-323, 2023 | 5 | 2023 |
| Description and evaluation of a pilot advanced pharmacy practice experience in addiction medicine LJ Loera, LG Hill, CM Zagorski, ML Jermain, CF Tirado American Journal of Pharmaceutical Education 87 (1), ajpe8926, 2023 | 5 | 2023 |
| “We do it ourselves”: strengths and opportunities for improving the practice of harm reduction K Claborn, J Samora, K McCormick, Q Whittfield, F Courtois, K Lozada, ... Harm Reduction Journal 20 (1), 70, 2023 | 2 | 2023 |
| Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in eleven US states LJ Loera, LG Hill, SB Torrez, T Puzantian, D Ventricelli, H Eukel, KE Evoy, ... 2021 ACCP VIRTUAL Annual Meeting, 2021 | 2 | 2021 |
| Policies regarding use of medications for opioid use disorder in professional recovery programs: A scoping review KM White, LG Hill, JC Perez, SB Torrez, CM Zagorski, LJ Loera Substance Abuse 43 (1), 749-755, 2022 | 1 | 2022 |
| Family Health History Day is Thanksgiving Day KM Kelly, E Yenser Journal of the American Pharmacists Association 63 (6), 1653-1654, 2023 | | 2023 |
| A wound care and immunization needs assessment for participants of a mobile syringe services program in Austin, TX TR Britton, MR Clague, CM Zagorski, LG Hill, LJ Loera Journal of the American Pharmacists Association 63 (1), 361-365. e1, 2023 | | 2023 |
Lucas G. HillClinical Associate Professor, The University of Texas at AustinVerified email at austin.utexas.edu
